Dr. Sahu's Laboratories

Dr. Sahu's Laboratories is an Indian pharmaceutical company that specializes in the production of niche Active Pharmaceutical Ingredients (APIs), impurity standards, and certified reference materials. Founded in early 2026, the firm provides a comprehensive range of services including custom synthesis, analytical consultancy, and R&D outsourcing to support global drug discovery and quality control efforts. Their extensive product portfolio covers diverse therapeutic categories such as oncology, cardiology, neurology, and metabolic diseases, featuring high-demand molecules like Semaglutide and Ibrutinib. The company operates with a strong focus on regulatory compliance, adhering to GMP, GLP, and ICH guidelines to ensure the reliability and traceability of its specialty materials.